JP2022532965A5 - - Google Patents
Info
- Publication number
- JP2022532965A5 JP2022532965A5 JP2021527899A JP2021527899A JP2022532965A5 JP 2022532965 A5 JP2022532965 A5 JP 2022532965A5 JP 2021527899 A JP2021527899 A JP 2021527899A JP 2021527899 A JP2021527899 A JP 2021527899A JP 2022532965 A5 JP2022532965 A5 JP 2022532965A5
- Authority
- JP
- Japan
- Prior art keywords
- protein preparation
- aqueous high
- preparation according
- concentration
- concentration protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862770337P | 2018-11-21 | 2018-11-21 | |
| US62/770,337 | 2018-11-21 | ||
| PCT/US2019/062596 WO2020106948A1 (en) | 2018-11-21 | 2019-11-21 | High concentration protein formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022532965A JP2022532965A (ja) | 2022-07-21 |
| JP2022532965A5 true JP2022532965A5 (enExample) | 2022-11-28 |
| JP7637618B2 JP7637618B2 (ja) | 2025-02-28 |
Family
ID=68916589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021527899A Active JP7637618B2 (ja) | 2018-11-21 | 2019-11-21 | 高濃度タンパク質製剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12036280B2 (enExample) |
| EP (1) | EP3883542A1 (enExample) |
| JP (1) | JP7637618B2 (enExample) |
| KR (1) | KR102944691B1 (enExample) |
| CN (1) | CN113164378A (enExample) |
| AU (1) | AU2019384160B2 (enExample) |
| BR (1) | BR112021009463A2 (enExample) |
| CA (1) | CA3118306A1 (enExample) |
| EA (1) | EA202191403A1 (enExample) |
| IL (1) | IL283229B2 (enExample) |
| MX (1) | MX2021005910A (enExample) |
| SG (1) | SG11202104166QA (enExample) |
| WO (1) | WO2020106948A1 (enExample) |
| ZA (1) | ZA202102816B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7235770B2 (ja) | 2018-05-10 | 2023-03-08 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 高濃度ｖｅｇｆ受容体融合タンパク質を含む製剤 |
| SG11202108627SA (en) | 2019-02-18 | 2021-09-29 | Lilly Co Eli | Therapeutic antibody formulation |
| AU2022343289A1 (en) * | 2021-09-09 | 2024-02-29 | Xeris Pharmaceuticals, Inc. | Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereof |
| IL326704A (en) * | 2023-08-24 | 2026-04-01 | Rezolute Inc | High-concentration anti-insulin receptor antibody formulations and their uses |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1142172B (it) * | 1978-10-19 | 1986-10-08 | Sandoz Ag | Nuovo impiego in terapeutica della ciclosporina-a e della diidrociclosporina-c |
| US6629949B1 (en) | 2000-05-08 | 2003-10-07 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6659982B2 (en) | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| WO2002011695A2 (en) * | 2000-08-07 | 2002-02-14 | Inhale Therapeutic Systems, Inc. | Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
| US20090208492A1 (en) * | 2007-06-14 | 2009-08-20 | Elan Pharmaceuticals, Inc. | Lyophilized Immunoglobulin Formulations and Methods of Preparation |
| US9072668B2 (en) * | 2010-03-09 | 2015-07-07 | Janssen Biotech, Inc. | Non-aqueous high concentration reduced viscosity suspension formulations of antibodies |
| US20110223208A1 (en) | 2010-03-09 | 2011-09-15 | Beth Hill | Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
| WO2012122544A2 (en) * | 2011-03-10 | 2012-09-13 | Board Of Regents, The University Of Texas System | Protein nanoparticle dispersions |
| CN103356490A (zh) * | 2012-03-29 | 2013-10-23 | 复旦大学 | 可直接固体化的交联食物蛋白稳定化纳米给药系统 |
| PL2849723T3 (pl) | 2012-05-18 | 2018-10-31 | Genentech, Inc. | Formulacje o wysokim stężeniu przeciwciał monoklonalnych |
| UA117466C2 (uk) * | 2012-12-13 | 2018-08-10 | Мерк Шарп Енд Доме Корп. | СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19 |
| IL312865B2 (en) * | 2013-09-11 | 2025-06-01 | Eagle Biologics Inc | Liquid protein formulations containing viscosity-lowering agents |
| EP2942050B1 (en) * | 2014-05-06 | 2022-09-07 | S.I.I.T. S.r.l.-Servizio Internazionale Imballaggi Termosaldanti | A sprayable oily composition based on liposoluble vitamins of the group d and use thereof |
| US20180000932A1 (en) * | 2014-12-31 | 2018-01-04 | Novelmed Therapeutics, Inc. | Formulation of aglycosylated therapeutic antibodies |
| WO2018067987A1 (en) * | 2016-10-06 | 2018-04-12 | Amgen Inc. | Reduced viscosity protein pharmaceutical formulations |
-
2019
- 2019-11-21 WO PCT/US2019/062596 patent/WO2020106948A1/en not_active Ceased
- 2019-11-21 IL IL283229A patent/IL283229B2/en unknown
- 2019-11-21 KR KR1020217018710A patent/KR102944691B1/ko active Active
- 2019-11-21 CN CN201980076726.4A patent/CN113164378A/zh active Pending
- 2019-11-21 MX MX2021005910A patent/MX2021005910A/es unknown
- 2019-11-21 AU AU2019384160A patent/AU2019384160B2/en active Active
- 2019-11-21 EA EA202191403A patent/EA202191403A1/ru unknown
- 2019-11-21 US US16/690,956 patent/US12036280B2/en active Active
- 2019-11-21 BR BR112021009463-6A patent/BR112021009463A2/pt unknown
- 2019-11-21 JP JP2021527899A patent/JP7637618B2/ja active Active
- 2019-11-21 SG SG11202104166QA patent/SG11202104166QA/en unknown
- 2019-11-21 EP EP19821379.5A patent/EP3883542A1/en active Pending
- 2019-11-21 CA CA3118306A patent/CA3118306A1/en active Pending
-
2021
- 2021-04-28 ZA ZA2021/02816A patent/ZA202102816B/en unknown
-
2024
- 2024-06-05 US US18/734,030 patent/US20240316195A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10391108B2 (en) | Pharmaceutical tetracycline composition for dermatological use | |
| JP5414542B2 (ja) | ビタミンｄおよびコルチコステロイドを有するポリアフロン局所組成物 | |
| AU2005294805B2 (en) | A mixture for transdermal delivery of low and high molecular weight compounds | |
| EP2391344B1 (en) | Compositions for nail and skin treatment | |
| JP6042343B2 (ja) | 毛髪成長のための組成物及び方法 | |
| FR2851470A1 (fr) | Composition pharmaceutique pour administration transdermique ou transmuqueuse | |
| FI3360575T3 (fi) | Ihon kautta annosteltavat farmaseuttiset koostumukset, jotka käsittävät vaikuttavia aineita | |
| JP2013508296A5 (enExample) | ||
| EP3269358A1 (en) | Composition for topical application, uses thereof, applicator device and kit of parts | |
| JP2010513500A5 (enExample) | ||
| FR3076456A1 (fr) | Huiles capillaires pour le traitement de fibres keratiniques | |
| RU2012120388A (ru) | Фармацевтические композиции, включающие производное камптотецина | |
| WO2014042043A9 (en) | Pharmaceutical composition containing luliconazole | |
| JP2017503866A (ja) | デュタステリドを含む自己乳化型薬物送達システムのための組成物 | |
| KR20110027838A (ko) | 광선 각화증을 치료하기 위한 국소 조성물 | |
| MX2021007393A (es) | Formulacion de solucion de proteinas que contiene una alta concentracion de un anticuerpo anti-vegf. | |
| ES2519240A2 (es) | Preparación de caspofungina de bajo contenido de impurezas, método para preparar la misma, y uso de la misma | |
| DK3122323T3 (en) | Formulation for personal hygiene | |
| JP2018505905A (ja) | 局所医薬製剤 | |
| FI3373976T3 (fi) | Topikaalisia formulaatioita ja niiden käyttöjä | |
| JP2010132607A (ja) | アトピー性皮膚炎治療用軟膏剤 | |
| FR3089815A1 (fr) | Agents cosmétiques destinés au conditionnement des fibres kératiniques | |
| US20210169897A1 (en) | Concentrated Fulvestrant Compositions | |
| JP5722364B2 (ja) | 医薬組成物 | |
| JP2013018737A (ja) | 凍結乾燥製剤及びその製造方法 |